Bruker Corp

Bruker Corp

BRKR

Get informed when a big investor buys or sells

+ Follow
Market Cap$8.96B
Close$

Compare to Similar Companies

P/E RatioDividendsReturn on EquityPrice-to-SalesDebt-to-Equity
Bruker CorpBruker Corp-84.20.34%-3%2.51
$65.83

Target Price by Analysts

18.4% upsideBruker Target Price DetailsTarget Price
$8.99

Current Fair Value

83.8% downside

Overvalued by 83.8% based on the discounted cash flow analysis.

Share Statistics

Market cap$8.96 Billion
Enterprise Value$11.13 Billion
Dividend Yield$0.20 (0.34%)
Earnings per Share$-0.15
Beta1.22
Outstanding Shares152,200,000

Return

Return on Equity-2.97%ROE
Return on Assets-1.18%
Return on Invested Capital0.51%

Valuation & Multiples

P/E Ratio-84.18P/E Ratio
PEG10.73PEG
Price to Sales2.53Price to Sales
Price to Book Ratio3.71Price to Book Ratio
Enterprise Value to Revenue3.18
Enterprise Value to EBIT454.38
Enterprise Value to Net Income-157
Total Debt to Enterprise0.21
Debt to Equity0.98Debt to Equity

Revenue Sources

No data

Insider Trades

Last Earnings Call

Report Date
August 4, 2026
EPS Estimate
$0.38
Average shareholder expectation
Revenue Estimate
$853.57 M
Average shareholder expectation

Next Earnings Call

Expected Date
November 2, 2026
EPS Estimate
$0.42
Average shareholder expectation
Revenue Estimate
$865.19 M
Average shareholder expectation

Institutional Put/Call Ratio

Market sentiment based on institutional option activity.

Put/Call Ratio0.0000▼ 12.34%
Total Calls-▼ 100.00%
Total Puts-▼ 100.00%

Institutional Ownership

Holdings and activity of institutional investors.

Ownership %0.03%▼ 94.36%
Total Invested$2.54M▼ 99.97%
Investors Holding12▼ 420.00%

ESG Score

No data

About Bruker Corp

6,000 employees
CEO: Frank Laukien

Bruker is enabling scientists to make breakthrough discoveries and develop new applications that improve the quality of human life. Bruker's high-performance scienti c instruments and high-value analytical and diagnostic solutions enable...